Original Article

Development of a nomogram for predicting the operative mortality of patients who underwent pneumonectomy for lung cancer: a population-based analysis

Xiangyang Yu, Shugeng Gao, Qi Xue, Fengwei Tan, Yushun Gao, Yousheng Mao, Dali Wang, Jun Zhao, Yin Li, Feng Wang, Hong Cheng, Chenguang Zhao, Juwei Mu

PDF Reporting Checklist COI Form Open Access

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Yusuke Tomita, Bryan Oronsky, Nacer Abrouk, Pedro Cabrales, Tony R. Reid, Min-Jung Lee, Akira Yuno, Jonathan Baker, Sunmin Lee, Jane B. Trepel

Open Access

A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database

Gang Lin, Kang Qi, Bing Liu, Haibo Liu, Jian Li

Open Access

Perioperative comparison of video-assisted thoracic surgery and open lobectomy for pT1-stage non-small cell lung cancer patients in China: a multi-center propensity score-matched analysis

Jinming Xu, Heng Ni, Yihe Wu, Jinlin Cao, Xingpeng Han, Lunxu Liu, Xiangning Fu, Yin Li, Xiaofei Li, Lin Xu, Yang Liu, Heng Zhao, Deruo Liu, Xin Peng, Jian Hu

PDF Reporting Checklist COI Form Open Access

Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT^®-Lung in context of the German Lung Cancer Screening Intervention trial (LUSI)

Sandra González Maldonado, Theron Johnson, Erna Motsch, Stefan Delorme, Rudolf Kaaks

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Impact of an enhanced recovery after surgery pathway on thoracoscopic lobectomy outcomes in non-small cell lung cancer patients: a propensity score-matched study

Céline Forster, Valérie Doucet, Jean Yannis Perentes, Etienne Abdelnour-Berchtold, Matthieu Zellweger, Mohamed Faouzi, Hasna Bouchaab, Solange Peters, Carlo Marcucci, Thorsten Krueger, Lorenzo Rosner, Michel Gonzalez

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)

Shinji Takeuchi, Noriko Yanagitani, Takashi Seto, Yoshihiro Hattori, Kadoaki Ohashi, Masahiro Morise, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Makoto Nishio, Shizuko Takahara, Takahiro Kawakami, Yasuhito Imai, Kenichi Yoshimura, Azusa Tanimoto, Akihiro Nishiyama, Toshinori Murayama, Seiji Yano

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Yusuke Tomita, Bryan Oronsky, Nacer Abrouk, Pedro Cabrales, Tony R. Reid, Min-Jung Lee, Akira Yuno, Jonathan Baker, Sunmin Lee, Jane B. Trepel

Open Access

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer

Parth A. Chodavadia, Corbin D. Jacobs, Frances Wang, Joseph K. Salama, Chris R. Kelsey, Jeffrey M. Clarke, Neal E. Ready, Jordan A. Torok

PDF Reporting Checklist COI Form Open Access

Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Masashi Ishihara, Ryosuke Ochiai, Terunobu Haruyama, Takahiko Sakamoto, Shigeru Tanzawa, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Tsuyoshi Ishida, Kiyotaka Watanabe, Nobuhiko Seki

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Sleeve lobectomy after neoadjuvant chemoimmunotherapy/chemotherapy for local advanced non-small cell lung cancer

Hengrui Liang, Chao Yang, Diego Gonzalez-Rivas, Yunpeng Zhong, Ping He, Hongsheng Deng, Jun Liu, Wenhua Liang, Jianxing He, Shuben Li

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma

Qingpeng Zeng, Jiagen Li, Nan Sun, Qi Xue, Yushun Gao, Jun Zhao, Yousheng Mao, Juwei Mu, Dali Wang, Shugeng Gao, Jie He

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

High indoleamine-2,3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Florian Kocher, Arno Amann, Kai Zimmer, Simon Geisler, Dietmar Fuchs, Renate Pichler, Dominik Wolf, Katharina Kurz, Andreas Seeber, Andreas Pircher

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment

Shenglin Ma, Meiqi Shi, Xueqin Chen, Yong Wang, Zhenhua Yang, Analyn Lizaso, Min Li, Haiyan Li, Lu Zhang, Xinru Mao, Xingxiang Xu, Yong Song

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

A nomogram for predicting the risk of lymph node metastasis in T1–2 non-small-cell lung cancer based on PET/CT and clinical characteristics

Xiayi Lv, Zhigang Wu, Jinlin Cao, Yeji Hu, Kai Liu, Xiaona Dai, Xiaoshuai Yuan, Yiqing Wang, Kui Zhao, Wang Lv, Jian Hu

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Association between dietary sodium, potassium intake and lung cancer risk: evidence from the prostate, lung, colorectal and ovarian cancer screening trial and the Women’s Health Initiative

Dongfang You, Mingzhi Zhang, Wenjing He, Danhua Wang, Yang Yu, Zhaolei Yu, Theis Lange, Sheng Yang, Yongyue Wei, Hongxia Ma, Zhibin Hu, Hongbing Shen, Feng Chen, Yang Zhao

PDF Reporting Checklist Peer Review File COI Form Open Access

Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for advanced non-small cell lung cancer patients with high PD-L1 tumor expression receiving pembrolizumab

Doran Ksienski, Elaine S. Wai, Deepu Alex, Nicole S. Croteau, Ashley T. Freeman, Angela Chan, Tiffany Patterson, Melissa Clarkson, Leathia Fiorino, Zia Poonja, David Fenton, Sarah Irons, Mary Lesperance

PDF Reporting Checklist Peer Review File COI Form Open Access

Identifying optimal candidates for primary tumor resection among metastatic non-small cell lung cancer patients: a population-based predictive model

Hengrui Liang, Zhichao Liu, Jun Huang, Jun Liu, Wei Wang, Jianfu Li, Shan Xiong, Caichen Li, Bo Cheng, Yi Zhao, Fei Cui, Jianxing He, Wenhua Liang

PDF Reporting Checklist Peer Review File COI Form Open Access

Phase I study of afatinib plus bevacizumab in patients with advanced non-squamous non-small cell lung cancer harboring EGFR mutations

Ryo Ko, Takehito Shukuya, Chiyo K. Imamura, Takaaki Tokito, Naoko Shimada, Ryo Koyama, Kazuhiko Yamada, Hidenobu Ishii, Koichi Azuma, Kazuhisa Takahashi

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Hyponatremia as a prognostic factor in non-small cell lung cancer: a systematic review and meta-analysis

Birgitte Sandfeld-Paulsen, Ninna Aggerholm-Pedersen, Anne Winther-Larsen

PDF Reporting Checklist Peer Review File COI Form Open Access

cGAS-STING pathway expression as a prognostic tool in NSCLC

Kristine Raaby Gammelgaard, Birgitte Sandfeld-Paulsen, Stine Høvring Godsk, Christina Demuth, Peter Meldgaard, Boe Sandahl Sorensen, Martin Roelsgaard Jakobsen

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Immune checkpoint inhibitors in oncogene-addicted non-small cell lung cancer: a systematic review and meta-analysis

Giorgia Guaitoli, Marcello Tiseo, Massimo Di Maio, Luc Friboulet, Francesco Facchinetti

PDF Reporting Checklist Peer Review File COI Form Open Access

Prognostic factors in older patients with wild-type epidermal growth factor receptor advanced non-small cell lung cancer: a multicenter retrospective study

Yurie Seto, Yoshiko Kaneko, Takako Mouri, Hiroyuki Fujii, Satomi Tanaka, Shinsuke Shiotsu, Osamu Hiranuma, Yoshie Morimoto, Masahiro Iwasaku, Tadaaki Yamada, Junji Uchino, Koichi Takayama

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Genomic profiling of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid of patients with lung adenocarcinoma

Seung Eun Lee, Ha Young Park, Jae Young Hur, Hee Joung Kim, In Ae Kim, Wan Seop Kim, Kye Young Lee

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Toxicity after volumetric modulated arc therapy for lung cancer: a monocentric retrospective study

Vincent Bourbonne, Alice Delafoy, François Lucia, Gilles Quéré, Olivier Pradier, Ulrike Schick

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Predictors of upstage and treatment strategies for stage IA lung cancers after sublobar resection for adenocarcinoma in situ and minimally invasive adenocarcinoma

Hang Su, Chang Gu, Yunlang She, Long Xu, Ping Yang, Huikang Xie, Shengnan Zhao, Chunyan Wu, Dong Xie, Chang Chen

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside

Xiaofei Wang, Zengtuan Xiao, Jialin Gong, Zuo Liu, Mengzhe Zhang, Zhenfa Zhang

PDF Reporting Checklist COI Form Open Access

Performance of various risk prediction models in a large lung cancer screening cohort in Gdańsk, Poland—a comparative study

Marcin Ostrowski, Franciszek Bińczyk, Tomasz Marjański, Robert Dziedzic, Sylwia Pisiak, Sylwia Małgorzewicz, Mariusz Adamek, Joanna Polańska, Witold Rzyman

PDF Data Sharing Statement COI Form Open Access

MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer

Shijun Zhao, Donghui Hou, Xiaomin Zheng, Wei Song, Xiaoqing Liu, Sicong Wang, Lina Zhou, Xiuli Tao, Lv Lv, Qi Sun, Yujing Jin, Lieming Ding, Li Mao, Ning Wu

PDF Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access

Association between aspirin use and lung cancer incidence depends on high-frequency use, bodyweight, and age in U.S. adults

Xuesi Dong, Jieyu He, Lijuan Lin, Ying Zhu, Chao Chen, Li Su, Yang Zhao, Ruyang Zhang, Yongyue Wei, Feng Chen, David C. Christiani

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

A preclinical research platform to evaluate photosensitizers for transbronchial localization and phototherapy of lung cancer using an orthotopic mouse model

Tsukasa Ishiwata, Takeshi Seki, Alexander Gregor, Masato Aragaki, Yamato Motooka, Tomonari Kinoshita, Terunaga Inage, Nicholas Bernards, Hideki Ujiie, Zhenchian Chen, Andrew Effat, Juan Chen, Gang Zheng, Koichiro Tatsumi, Kazuhiro Yasufuku

PDF Video Reporting Checklist Data Sharing Statement COI Form Open Access

Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome

Alberto Pavan, Andrea Boscolo Bragadin, Lorenzo Calvetti, Alessandra Ferro, Elisabetta Zulato, Ilaria Attili, Giorgia Nardo, Alessandro Dal Maso, Stefano Frega, Andrea Giovanni Menin, Matteo Fassan, Fiorella Calabrese, Giulia Pasello, Valentina Guarneri, Giuseppe Aprile, PierFranco Conte, Rafael Rosell, Stefano Indraccolo, Laura Bonanno

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Prognostic significance of cribriform adenocarcinoma of the lung: validation analysis of 1,057 Japanese patients with resected lung adenocarcinoma and a review of the literature

Naoki Nakajima, Akihiko Yoshizawa, Mariyo Rokutan-Kurata, Misa Noguchi, Yuki Teramoto, Shinji Sumiyoshi, Kyoko Kondo, Makoto Sonobe, Masatsugu Hamaji, Toshi Menju, Hiroshi Date, Hironori Haga

PDF Reporting Checklist Peer Review File COI Form Open Access

Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients

Lázaro Antonio Campanha Novaes, Luciane Sussuchi da Silva, Pedro De Marchi, Rodrigo de Oliveira Cavagna, Flavia Escremim de Paula, Maicon Fernando Zanon, Adriane Feijó Evangelista, Eduardo Caetano Albino da Silva, Vinícius Duval da Silva, Letícia Ferro Leal, Rui Manuel Reis

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Comprehensive genomic profiling of combined small cell lung cancer

Jing Zhang, Liping Zhang, Jie Luo, Tao Ge, Pengyu Fan, Liangdong Sun, Likun Hou, Junqiang Li, Huansha Yu, Chunxiao Wu, Yuming Zhu, Chunyan Wu, Gening Jiang, Giancarlo Troncone, Jyoti Malhotra, Katsuhiro Okuda, Mariacarmela Santarpia, Rita Zamarchi, Taichiro Goto, Andrés F. Cardona, Jianfang Xu, Qiankun Chen, Zhonghong Zhang, Peng Zhang, written on behalf of the AME Lung Cancer Collaborative Group

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

In small cell lung cancer patients treated with RRx-001, a downregulator of CD47, decreased expression of PD-L1 on circulating tumor cells significantly correlates with clinical benefit

Yusuke Tomita, Bryan Oronsky, Nacer Abrouk, Pedro Cabrales, Tony R. Reid, Min-Jung Lee, Akira Yuno, Jonathan Baker, Sunmin Lee, Jane B. Trepel

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401)

Masaaki Okajima, Satoru Miura, Satoshi Watanabe, Hiroshi Tanaka, Kazuhiko Ito, Takashi Ishida, Masato Makino, Akira Iwashima, Naoya Matsumoto, Kazuhiro Sato, Kosuke Ichikawa, Tetsuya Abe, Hirohisa Yoshizawa, Toshiaki Kikuchi

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Cholesterol synthesis disruption combined with a molecule-targeted drug is a promising metabolic therapy for EGFR mutant non-small cell lung cancer

Youli Luo, Yunpeng Yang, Peijian Peng, Jianhua Zhan, Zhihui Wang, Zhiquan Zhu, Zhonghan Zhang, Lin Liu, Wenfeng Fang, Li Zhang

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

Clinical types of checkpoint inhibitor-related pneumonitis in lung cancer patients: a multicenter experience

Xinqing Lin, Haiyi Deng, Likun Chen, Di Wu, Xiaobo Chen, Yilin Yang, Tao Chen, Xiaohong Xie, Zhanhong Xie, Ming Liu, Ming Ouyang, Yinyin Qin, Shiyue Li, Nanshan Zhong, Jeffrey P. Gregg, Nobuyuki Horita, Yong Song, Chengzhi Zhou

PDF Reporting Checklist Data Sharing Statement COI Form Open Access

---

Review Article

Mediastinal staging for non-small-cell lung cancer

Virginia Leiro-Fernández, Alberto Fernández-Villar

PDF COI Form Open Access

Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?

Lizza E. L. Hendriks, Jordi Remon, Jessica Menis, Benjamin Besse

PDF COI Form Open Access

Controversies in the role of radiotherapy in pleural mesothelioma

Gerard G. Hanna, Thomas John, David L. Ball

PDF Peer Review File COI Form Open Access

Radiotherapy for thymic epithelial tumours: a review

Krisztian Süveg, Paul Martin Putora, Markus Joerger, Thomas Iseli, Galina Farina Fischer, Karlheinz Ammann, Markus Glatzer

PDF Peer Review File COI Form Open Access

Immunotherapy in small cell lung cancer: one step at a time: a narrative review

Daphne W. Dumoulin, Anne-Marie C. Dingemans, Joachim G. J. V. Aerts, Jordi Remon, Dirk K. M. De Ruysscher, Lizza E. L. Hendriks

PDF Reporting Checklist COI Form Open Access

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy

Ben G. L. Vanneste, Evert J. Van Limbergen, Kobe Reynders, Dirk De Ruysscher

PDF COI Form Open Access

Lung cancer screening: who pays? who receives?—the Chinese perspective

Yang Zhang, Haiquan Chen

PDF COI Form Open Access

Systematic review of stereotactic body radiotherapy in stage III non-small cell lung cancer

Olwen Leaman Alcibar, Ernest Nadal, Inmaculada Romero Palomar, Arturo Navarro-Martin

PDF COI Form Open Access

Neoadjuvant treatment of stage IIIA-N2 in EGFR-Mutant/ALK-rearranged non-small cell lung cancer

Roxana Reyes, Noemi Reguart

PDF Reporting Checklist Peer Review File COI Form Open Access

Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer

Boris Duchemann, Jordi Remon, Marie Naigeon, Lydie Cassard, Jean Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Edouard Auclin, Aude Desnoyer, Benjamin Besse, Nathalie Chaput

PDF COI Form Open Access

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer

Monika Pradhan, Mathieu Chocry, Don L. Gibbons, Boris Sepesi, Tina Cascone

PDF Peer Review File COI Form Open Access

Lung cancer screening and smoking cessation efforts

Dana Moldovanu, Harry J. de Koning, Carlijn M. van der Aalst

PDF Peer Review File COI Form Open Access

Minimal invasive surgery in locally advanced N2 non-small cell lung cancer

Ana Karina Patané

PDF COI Form Open Access

Induction treatment in patients with stage III non-small cell lung cancer

Ramón Palmero, Noelia Vilariño, Arturo Navarro-Martín, Ernest Nadal

PDF COI Form Open Access

Evolving target volume concepts in locally advanced non-small cell lung cancer

Ursula Nestle, Cecile Le Pechoux, Dirk De Ruysscher

PDF Peer Review File COI Form Open Access

Surgery after neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer

Caroline Huynh, Logan A. Walsh, Jonathan D. Spicer

PDF Peer Review File COI Form Open Access

Exploring natural killer cell immunology as a therapeutic strategy in lung cancer

Jonas B. Hess, Kate D. Sutherland, Sarah A. Best

PDF Peer Review File COI Form Open Access

A narrative review of invasive diagnostics and treatment of early lung cancer

Robert Dziedzic, Tomasz Marjański, Witold Rzyman

PDF Reporting Checklist Peer Review File COI Form Open Access

Current progress and mechanisms of bone metastasis in lung cancer: a narrative review

Shengyu Wu, Yue Pan, Yanyu Mao, Yu Chen, Yayi He

PDF Reporting Checklist COI Form Open Access

Should sublobar resection be offered for screening-detected lung nodules?

Alan D. L. Sihoe

PDF COI Form Open Access

Lung cancer screening: targeting the hard to reach—a review

Guido Van Hal, Paloma Diab Garcia

PDF Peer Review File COI Form Open Access

Holding our breath: the promise of tissue-resident memory T cells in lung cancer

Claire Marceaux, Clare E. Weeden, Claire L. Gordon, Marie-Liesse Asselin-Labat

PDF COI Form Open Access

Prophylactic cranial irradiation in SCLC

Rafal Suwinski

PDF COI Form Open Access

Implementation of lung cancer screening: what are the main issues?

Carlijn M. van der Aalst, Kevin ten Haaf, Harry J. de Koning, for the 4-IN-THE-LUNG-RUN Consortium

PDF COI Form Open Access

Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System

Claudia I. Henschke, David F. Yankelevitz, Artit Jirapatnakul, Rowena Yip, Vivian Reccoppa, Charlene Benjamin, Tserling Llamo, Angel Williams, Simon Liu, Daniel Max, Samuel M. Aguayo, Providencia Morales, Brian J. Igel, Hamed Abbaszadegan, Peter A. Fredricks, Daniel P. Garcia, Paska A. Permana, Janet Fawcett, Samir Sultan, Lorenza A. Murphy

PDF COI Form Open Access

Managing of screening-detected sub-solid nodules—a European perspective

Sara Ricciardi, Richard Booton, Renè Horsleben Petersen, Maurizio Infante, Marco Scarci, Giulia Veronesi, Giuseppe Cardillo

PDF COI Form Open Access

Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?

Anton Schreuder, Ernst T. Scholten, Bram van Ginneken, Colin Jacobs

PDF COI Form Open Access

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question

Paul Van Houtte, Luigi Moretti, Florian Charlier, Martine Roelandts, Dirk Van Gestel

PDF Peer Review File COI Form Open Access

Narrative review: mesenchymal-epithelial transition inhibitors—meeting their target

Danish Safi, Taher Abu Hejleh, Muhammad Furqan

PDF Reporting Checklist Peer Review File COI Form Open Access

Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)

Małgorzata Łazar-Poniatowska, Artur Bandura, Rafał Dziadziuszko, Jacek Jassem

PDF Reporting Checklist Peer Review File COI Form Open Access

Overdiagnosis in lung cancer screening

David F. Yankelevitz, Claudia I. Henschke

PDF COI Form Open Access

Dose and fractionation schedules in radiotherapy for non-small cell lung cancer

Lucyna Kepka, Joanna Socha

PDF COI Form Open Access

Challenges in the target volume definition of lung cancer radiotherapy

Susan Mercieca, José S. A. Belderbos, Marcel van Herk

PDF Peer Review File COI Form Open Access

Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer

Akira Hamada, Junichi Soh, Tetsuya Mitsudomi

PDF Peer Review File COI Form Open Access

Narrative review of lung cancer treatment at the time of COVID-19 pandemia: pitfall and issues

Francesca Casaluce, Cesare Gridelli

PDF Reporting Checklist COI Form Open Access

Lung cancer screening strategy for non-high-risk individuals: a narrative review

Fangqiu Fu, Yaodong Zhou, Yang Zhang, Haiquan Chen

PDF Reporting Checklist Peer Review File COI Form Open Access

The knowns & unknowns of pulmonary toxicity following immune checkpoint inhibitor therapies: a narrative review

Alistair R. Miller, Renee Manser

PDF Reporting Checklist Peer Review File COI Form Open Access

Thoracic radiotherapy in small cell lung cancer—a narrative review

Antonin Levy, Angela Botticella, Cécile Le Péchoux, Corinne Faivre-Finn

PDF Reporting Checklist COI Form Open Access

Prognostic factors in potentially resectable stage III non-small cell lung cancer receiving neoadjuvant treatment—a narrative review

Virginia Calvo, Carlos Aliaga, Carlos Carracedo, Mariano Provencio

PDF Reporting Checklist COI Form Open Access

Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival

Ana Casal-Mouriño, Alberto Ruano-Ravina, María Lorenzo-González, Ángeles Rodríguez-Martínez, Alexandra Giraldo-Osorio, Leonor Varela-Lema, Tara Pereiro-Brea, Juan Miguel Barros-Dios, Luis Valdés-Cuadrado, Mónica Pérez-Ríos

PDF COI Form Open Access

Immunotherapy in oncogene addicted non-small cell lung cancer

Luke McLean, Jose Luis Leal, Benjamin J. Solomon, Thomas John

PDF Peer Review File COI Form Open Access

The radiologist’s role in lung cancer screening

Annemiek Snoeckx, Caro Franck, Mario Silva, Mathias Prokop, Cornelia Schaefer-Prokop, Marie-Pierre Revel

PDF COI Form Open Access

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research

Eugenia Vlaskou Badra, Michael Baumgartl, Silvia Fabiano, Aurélien Jongen, Matthias Guckenberger

PDF Peer Review File COI Form Open Access

Managing screening-detected subsolid nodules—the Asian perspective

Masaaki Sato, Shun-Mao Yang, Dong Tian, Nakajima Jun, Jang-Ming Lee

PDF COI Form Open Access

Screen-detected solid nodules: from detection of nodule to structured reporting

Mario Silva, Gianluca Milanese, Roberta E. Ledda, Ugo Pastorino, Nicola Sverzellati

PDF COI Form Open Access

Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer

Steven Bozinovski, Amanda Vannitamby, Kanishka Rangamuwa, Savreet Aujla, Hao Wang, Christian Aloe, Louis Irving, Tracy T. Leong, Daniel P. Steinfort

PDF Peer Review File COI Form Open Access

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

Francesco Passiglia, Valeria Cetoretta, Marco De Filippis, Valerio Napoli, Silvia Novello

PDF COI Form Open Access

Latest CT technologies in lung cancer screening: protocols and radiation dose reduction

Marleen Vonder, Monique D. Dorrius, Rozemarijn Vliegenthart

PDF COI Form Open Access

Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations

Roberto Ferrara, Diego Signorelli, Claudia Proto, Arsela Prelaj, Marina Chiara Garassino, Giuseppe Lo Russo

PDF COI Form Open Access

---

Editorial

Prognostic models for immunotherapy: emerging factors for an evolving treatment landscape

Howard West

PDF COI Form Open Access

Robotic-assisted thoracoscopic surgery for clinically stage IIIA (c-N2) NSCLC—is it justified?

Walter Weder, Katarzyna Furrer, Isabelle Opitz

PDF COI Form Open Access

Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?

Vivek Verma, Joe Y. Chang

PDF COI Form Open Access

Endocrine immune-related adverse events: a double-edged sword?

Michelle Rengarajan, Justin F. Gainor

PDF COI Form Open Access

---

Review Article

Added benefits of early detection of other diseases on low-dose CT screening

Rowena Yip, Artit Jirapatnakul, Minxia Hu, Xiangmeng Chen, Dan Han, Teng Ma, Yeqing Zhu, Mary M. Salvatore, Laurie R. Margolies, David F. Yankelevitz, Claudia I. Henschke, for the I-ELCAP Investigators

PDF COI Form Open Access

---

Case Report

Response to the combination use of pazopanib with olaratumab in a patient with lung-metastatic embryonal rhabdomyosarcoma: a case report

Tuo Xing, Yalei Zhang, Xukai Li, Minzhang Guo, Wenhua Liang, Jianxing He

PDF Reporting Checklist COI Form Open Access

Safety of lorlatinib following alectinib-induced pneumonitis in two patients with ALK-rearranged non-small cell lung cancer: a case series

Nathaniel J. Myall, Amy Q. Lei, Heather A. Wakelee

PDF Reporting Checklist Peer Review File COI Form Open Access

---